Atropine sulfate opht
Ended Awarded
- Contract number
- SPE2DX25FASYS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,897
Award facts
- Contract value 100% obligated
- $2,896.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,896.56 for Atropine Sulfate Ophthalmic on July 22, 2025. This firm fixed-price delivery order, which is set to be completed by July 23, 2025, will be performed at the company's Park Ridge facility and is funded through the Defense Department's Medical Supply Chain function. The contract represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, a single-award vehicle valued at $499,999,999 and valid through November 2026, which authorizes the issuance of firm fixed-price delivery orders for pharmaceutical items supporting military health facilities worldwide.
Atropine Sulfate Ophthalmic is a mydriatic medication commonly used in military and federal healthcare settings for diagnostic and therapeutic ophthalmic procedures. This delivery order exemplifies DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement markets without set-aside designations. The company's portfolio encompasses an extensive range of pharmaceutical products, from specialty medications to biologics, demonstrating its capacity to fulfill diverse medical supply requirements across Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DX25FASYS?
SPE2DX25FASYS was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 22, 2025.
How much is contract SPE2DX25FASYS worth?
The government has obligated $2,897 on SPE2DX25FASYS.
Is contract SPE2DX25FASYS an order under another contract?
Yes. SPE2DX25FASYS is a delivery order under SPE2DX15D9903, an indefinite delivery contract.
Was contract SPE2DX25FASYS competed?
The extent of competition for SPE2DX25FASYS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award